You Are Here

FDA approves shock wave device for treatment of diabetic foot ulcers

On December 28, 2017, the FDA gave approval for the Dermapace System, a shock wave device intended to be used in the treatment of chronic, full-thickness diabetic foot ulcers. The device uses pulses of energy, similar to sound waves, to mechanically stimulate the wound. Read more.

Related posts

Leave a Comment

Wound Care is Important. Please spread the word :)

RSS5k
Follow by Email102k
Facebook4k
Facebook